Management of dry eye disease to optimize cataract surgery outcomes: Two tables for a daily clinical practice.

Cataract Cataracte Chirurgie Dry eye disease Ocular surface Outcomes Patient satisfaction Résultats Satisfaction du patient Sicca syndrome Surface oculaire Surgery Syndrome sicca Œil sec

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 06 03 2019
accepted: 11 03 2019
pubmed: 29 7 2019
medline: 14 2 2020
entrez: 29 7 2019
Statut: ppublish

Résumé

The increase in life expectancy has resulted in a greater number of patients presenting for cataract surgery as well as an increasing prevalence of dry eye disease (DED) symptoms or signs noted in these patients. Low grade and/or non-symptomatic DED is common and can be exacerbated after surgery. DED can induce errors in IOL power calculation. DED can impair the visual prognosis and patient comfort after cataract surgery, leading to dissatisfaction of both the patient and the surgeon. Hence, preoperative evaluation for DED for all cataract candidates is crucial to mitigate these risks. To optimize clinical efficiency during the screening examination, we propose a strategy of three levels of DED screening, according to a patient's risk of DED given his or her history. We also propose a summary of the main clinical points before, during and after cataract surgery in eyes with DED.

Identifiants

pubmed: 31351686
pii: S0181-5512(19)30352-3
doi: 10.1016/j.jfo.2019.03.032
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-912

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

M Labetoulle (M)

Service d'Ophtalmologie, hôpital Bicêtre, AP-HP, Université Paris Sud, 94275 Le Kremlin-Bicêtre, France; Center for Immunology of Viral infections and Autoimmune diseases (IMVA). IDMIT Infrastructure (http://www.idmitcenter.fr). CEA, Université Paris Sud, Inserm U1184, 18, route du Panorama, 92265, Fontenay-aux-Roses cedex, France. Electronic address: marc.labetoulle@aphp.fr.

A Rousseau (A)

Service d'Ophtalmologie, hôpital Bicêtre, AP-HP, Université Paris Sud, 94275 Le Kremlin-Bicêtre, France; Center for Immunology of Viral infections and Autoimmune diseases (IMVA). IDMIT Infrastructure (http://www.idmitcenter.fr). CEA, Université Paris Sud, Inserm U1184, 18, route du Panorama, 92265, Fontenay-aux-Roses cedex, France.

C Baudouin (C)

Centre Hospitalier des Quinze-Vingts, Service III, 28, rue de Charenton, 75012 Paris France; Institut de la Vision, 17, rue Moreau, 75012 Paris France; Hôpital Ambroise Paré, AP-HP, Boulogne, Université Versailles Saint-Quentin en Yvelines, 9 avenue Charles-de-Gaulle, 92104 Boulogne-Billancourt, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH